uterine neoplasm: ['Tumors of the UTERUS.']
Other benign neoplasm of uterus: Corpus uteri
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_CORPUS_UTERI
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly females |
293218 |
2. Check conditionsNone |
293218 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
284 |
4. Check minimum number of eventsNone |
284 |
5. Include endpointsNone |
284 |
6. Filter based on genotype QC (FinnGen only) |
274 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D26
- Name in latin
- Neoplasma benignum corporis uteri
Similar endpoints
↥List of similar endpoints to
Other benign neoplasm of uterus: Corpus uteri
based on the number of shared cases.
Similar with more cases:
- Other benign neoplasms of uterus
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1799 | 1799 | - |
| Only index persons | 1700 | 1700 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | - |
| Only index persons | 0.06 | 0.06 | - |
| Median age at first event (years) | |||
| Whole population | - | 49.00 | - |
| Only index persons | - | 48.68 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 274 | 274 | - |
| Unadjusted period prevalence (%) | 0.10 | 0.10 | - |
| Median age at first event (years) | 47.53 | 47.53 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 284
- Matched controls
- 2840
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D26.1
ICD-10 Finland
Other benign neoplasm: Corpus uteri
+∞
261.7
209
*
2191A
ICD-9 Finland
Other benign neoplasm of uterus, Corpus uteri
+∞
82.4
75
*
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
9.1
51.9
74
106
LCA06
NOMESCO Finland
Biopsy of endometrium
3.6
21.0
92
334
N84.0
ICD-10 Finland
Polyp of corpus uteri
4.1
20.1
65
191
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
5.1
19.2
45
102
LCD00
NOMESCO Finland
Hysterectomy
4.6
16.3
42
103
8305
FHL
Supravaginal amputation or resection
5.6
9.8
19
36
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.6
8.7
56
243
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
2.7
8.6
53
225
ULC02
NOMESCO Finland
Hysteroscopy
3.3
8.5
34
113
WX704
NOMESCO Finland
Intubation
3.2
8.5
36
124
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.9
6.8
119
767
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
111
792
1.66
4.02
2.4
2.2
55.49
60.48
u/l
0.43
105
713
21
86
2.56
3.64
1.3
1.3
—
—
—
0
0
53
330
1.75
3.10
5.1
4.5
35.33
33.62
%
0.53
33
207
165
1356
1.52
2.96
6.6
5.5
10.37
9.90
umol/l
0.29
160
1267
107
804
1.53
2.93
3.5
2.8
32.84
28.66
u/l
0.66
99
759
24
116
2.17
2.92
1.3
1.4
—
—
—
0
0
82
600
1.52
2.48
2.5
2.1
2.80
3.26
mg/l
1.24
71
508
6
12
5.08
2.41
1.0
1.2
6.32
5.49
mmol/l
—
6
12
15
65
2.38
2.36
1.4
1.4
—
—
—
0
0
143
1187
1.41
2.18
5.8
5.5
28.26
29.14
%
0.40
130
1104
145
1207
1.41
2.17
2.7
2.3
—
—
—
0
0
72
531
1.48
2.07
1.7
1.7
640000426.92
11792927.53
pmol/l
1.36
60
424
11
44
2.56
2.03
1.2
1.5
—
—
—
0
0
9
32
2.87
2.02
1.1
1.4
8.91
7.43
mmol/l
—
9
24
139
1178
1.35
1.75
5.4
5.3
57.29
56.28
%
0.41
125
1096
162
1406
1.35
1.74
3.9
4.2
6.50
6.54
mmol/l
0.06
149
1296
8
31
2.63
1.67
1.4
1.4
—
—
—
0
0
61
456
1.43
1.62
1.8
1.7
1187.24
1249.53
nmol/l
0.23
46
332
8
32
2.54
1.61
1.4
1.3
—
—
—
0
0
8
32
2.54
1.61
1.4
1.3
—
—
—
0
0
8
33
2.46
1.55
1.4
1.5
—
—
—
0
0
5
15
3.37
1.53
1.0
1.2
—
—
—
0
0
7
27
2.63
1.52
1.3
1.1
—
—
—
0
0
51
673
0.70
1.46
3.6
3.1
0.26
0.44
e6/l
0.77
42
488
173
1543
1.31
1.41
3.6
2.9
57.06
42.16
u/l
0.94
163
1423
13
67
1.99
1.40
1.2
1.1
—
—
—
0
0
94
773
1.32
1.38
3.6
3.7
14.31
7.47
mg/mmol
0.50
51
431
5
17
2.97
1.36
1.0
1.0
—
—
—
0
0
148
1298
1.29
1.34
7.7
5.7
1.24
1.22
mmol/l
2.18
132
1102
213
1963
1.34
1.33
8.6
7.1
82.19
76.11
u/l
1.15
207
1812
39
279
1.46
1.32
5.8
4.3
1.12
1.05
mmol/l
0.75
32
251
6
24
2.53
1.31
1.2
1.1
—
—
—
0
0
8
34
2.39
1.30
1.4
1.3
—
—
—
0
0
8
34
2.39
1.30
1.4
1.3
—
—
—
0
0
8
34
2.39
1.30
1.4
1.3
—
—
—
0
0
109
926
1.29
1.25
3.1
3.4
19.00
28.44
ng/l
0.73
72
633
9
45
2.03
1.24
1.0
1.3
—
—
—
0
0
83
686
1.30
1.16
2.6
2.9
971.91
935.41
ng/l
0.03
62
584
125
1088
1.27
1.16
5.9
3.9
34.92
35.85
g/l
1.23
120
1010
223
2084
1.33
1.15
4.6
4.5
14.44
14.81
pmol/l
1.14
190
1888
270
2610
1.70
1.13
17.2
15.6
70.73
69.61
umol/l
0.23
270
2610
207
1922
1.28
1.08
4.7
4.4
14.40
12.35
mm/h
1.01
189
1755
12
67
1.83
1.06
5.5
5.0
21.82
23.52
mg/l
0.11
12
51
12
67
1.83
1.06
5.5
5.0
44.68
37.79
mg/l
0.27
12
51
7
33
2.15
1.06
1.0
1.0
—
—
—
0
0
251
2397
1.41
1.04
5.6
5.4
1.83
1.88
mu/l
0.32
211
2190
272
2642
1.70
0.99
12.2
10.5
25.71
23.40
u/l
0.72
259
2532
17
257
0.64
0.99
5.9
3.2
—
—
—
0
0
5
23
2.19
0.98
5.0
2.2
—
—
—
0
0
30
404
0.71
0.97
3.0
2.8
1.25
1.19
e6/l
0.05
20
214
11
62
1.81
0.95
1.4
2.0
—
—
—
0
0
6
28
2.17
0.92
3.5
2.7
13.67
13.37
%
—
6
28
12
71
1.72
0.90
2.8
1.6
26450.67
3710.07
u/l
—
6
32
73
859
0.80
0.90
3.9
3.2
—
—
—
0
0
133
1193
1.22
0.88
6.3
5.0
1.24
1.22
mmol/l
1.85
122
1084
26
188
1.42
0.87
3.7
2.4
65.07
66.93
g/l
0.43
19
171
278
2727
1.92
0.85
23.1
19.9
4.35
4.39
e12/l
0.91
273
2646
278
2725
1.96
0.84
23.2
19.8
38.84
39.57
%
1.06
252
2545
41
323
1.31
0.82
4.5
6.4
—
—
—
0
0
10
58
1.75
0.80
1.5
1.3
—
—
—
0
0
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
110
980
1.20
0.76
4.9
4.2
—
—
—
0
0
9
54
1.69
0.75
1.4
1.6
226.89
304.27
mu/l
—
9
48
6
106
0.56
0.74
1.0
1.1
—
—
—
0
0
6
106
0.56
0.74
1.0
1.1
—
—
—
0
0
118
1061
1.19
0.73
2.4
1.9
101.83
99.74
pmol/l
0.17
67
476
13
84
1.57
0.73
4.0
2.1
7.81
9.84
g/l
—
7
76
264
2567
1.40
0.72
16.9
15.0
139.76
139.85
mmol/l
0.23
256
2493
102
907
1.19
0.71
4.2
3.2
2.37
2.37
mmol/l
0.01
79
788
257
2490
1.34
0.71
14.9
12.9
18.64
20.99
mg/l
0.62
210
1921
44
359
1.27
0.69
3.0
2.2
13.02
13.19
umol/l
0.06
36
329
72
621
1.21
0.69
1.6
1.4
—
—
—
0
0
40
323
1.28
0.68
3.0
2.2
2.42
2.42
g/l
0.00
34
296
69
594
1.21
0.68
2.4
2.0
—
—
—
0
0
13
86
1.54
0.67
4.8
2.1
—
—
—
0
0
29
368
0.76
0.66
2.9
3.0
7.78
4.59
e6/l
0.51
19
181
10
62
1.64
0.66
1.1
1.2
—
—
—
0
0
10
63
1.61
0.62
1.1
1.7
520.80
228.97
ug/l
—
10
57
0
21
0.00
0.60
0.0
1.1
—
76.33
—
0
21
0
21
0.00
0.60
0.0
1.1
—
26.29
—
0
21
13
89
1.48
0.59
1.3
2.1
—
—
—
0
0
6
35
1.73
0.58
2.3
1.6
—
—
—
0
0
32
258
1.27
0.57
5.8
6.3
1.88
1.41
mmol/l
0.38
24
215
125
1149
1.16
0.57
2.9
2.3
79.43
79.99
nmol/l
0.09
109
1017
23
178
1.32
0.55
1.4
1.5
—
—
—
0
0
68
597
1.18
0.55
3.7
2.5
328.81
6394.21
umol/l
2.91
52
508
11
158
0.68
0.54
1.0
1.3
—
—
—
0
0
230
2375
0.83
0.54
13.8
12.5
76.49
79.46
ml/min/173m2
1.18
164
1906
6
39
1.55
0.53
1.8
1.5
—
—
—
0
0
9
65
1.40
0.51
1.2
1.2
—
—
—
0
0
57
499
1.18
0.48
1.3
1.3
18.19
34.81
iu/ml
1.12
15
168
263
2576
1.28
0.47
17.1
15.1
3.95
3.93
mmol/l
0.55
255
2493
56
494
1.17
0.43
1.3
1.3
16.08
12.99
u/ml
0.09
18
184
118
1098
1.13
0.43
10.4
11.1
1.19
1.17
inr
0.08
27
337
5
32
1.57
0.42
1.0
1.7
38.08
37.43
u/l
—
5
27
18
226
0.78
0.41
2.5
3.4
1.24
1.24
mmol/l
0.09
18
192
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
135
1272
1.12
0.39
4.5
4.1
0.00
0.00
estimate
-0.00
21
265
11
80
1.39
0.39
1.3
1.3
—
2.35
—
0
10
136
1282
1.12
0.39
6.4
5.4
0.00
0.00
estimate
-0.00
18
249
9
66
1.38
0.39
2.8
1.4
—
—
—
0
0
137
1293
1.12
0.38
4.5
4.1
0.00
0.00
estimate
-0.00
19
250
15
191
0.77
0.38
2.1
1.6
—
—
—
0
0
152
1443
1.11
0.38
9.5
8.9
4.02
3.89
e9/l
0.30
137
1268
229
2349
0.87
0.37
6.4
5.7
39.33
39.26
mmol/mol
0.04
203
2161
242
2473
0.86
0.37
5.0
4.5
1.59
1.62
mmol/l
0.34
215
2266
11
81
1.37
0.36
1.3
1.2
—
3.26
—
0
16
6
42
1.44
0.36
1.7
1.5
—
—
—
0
0
117
1101
1.11
0.34
3.7
2.8
96.37
89.10
ug/l
0.25
109
1010
33
286
1.17
0.33
4.8
3.8
2.74
7.36
ug/l
1.85
28
238
16
128
1.26
0.32
2.0
1.4
—
—
—
0
0
76
700
1.12
0.32
4.2
4.5
0.00
0.00
estimate
-0.00
19
255
18
147
1.24
0.31
2.1
1.6
—
—
—
0
0
7
97
0.71
0.31
1.7
1.7
1.18
1.19
g/l
—
7
92
10
75
1.35
0.30
1.6
2.2
32.94
37.71
g/l
—
5
68
10
75
1.35
0.30
1.3
1.3
—
—
—
0
0
155
1487
1.09
0.29
3.0
2.9
—
—
—
0
0
67
618
1.11
0.28
1.2
1.3
0.66
2.21
u/ml
—
9
155
11
86
1.29
0.26
2.2
1.6
—
—
—
0
0
9
75
1.21
0.25
2.2
1.7
—
—
—
0
0
11
87
1.28
0.24
1.3
1.2
—
4.48
—
0
5
15
125
1.21
0.23
1.7
1.4
—
—
—
0
0
7
93
0.75
0.23
1.7
1.7
0.25
0.23
g/l
—
7
87
19
220
0.85
0.22
1.4
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
34
308
1.12
0.20
3.6
2.3
21.21
21.76
%
0.10
26
258
6
49
1.23
0.20
1.0
1.4
—
—
—
0
0
6
49
1.23
0.20
1.0
1.4
—
—
—
0
0
80
759
1.08
0.19
1.7
2.0
122.22
145.97
u/l
0.59
74
716
7
58
1.21
0.18
2.7
1.4
—
—
—
0
0
246
2491
0.91
0.18
4.8
4.6
4.89
4.85
mmol/l
0.31
221
2284
5
68
0.73
0.17
1.4
2.3
0.00
0.00
g/l
—
5
63
5
69
0.72
0.17
1.4
2.3
0.00
0.00
g/l
—
5
64
5
70
0.71
0.17
1.4
2.3
0.00
0.08
g/l
—
5
65
62
586
1.07
0.16
2.1
1.6
1.13
0.99
mg/l
0.28
51
457
8
71
1.13
0.16
2.3
2.3
—
—
—
0
0
11
92
1.20
0.16
2.3
1.8
—
—
—
0
0
13
111
1.18
0.16
1.5
1.4
—
—
—
0
0
18
202
0.88
0.15
1.4
1.7
—
—
—
0
0
11
93
1.19
0.14
1.9
1.5
—
—
—
0
0
18
201
0.89
0.14
1.3
1.2
264.52
150.90
iu/ml
—
10
89
234
2368
0.93
0.13
4.3
4.0
1.33
1.24
mmol/l
1.50
211
2148
41
386
1.07
0.12
2.0
1.8
—
—
—
0
0
44
464
0.94
0.11
1.4
1.4
—
—
—
0
0
243
2452
0.94
0.10
5.0
4.7
5.85
5.85
mmol/l
0.00
218
2226
16
144
1.12
0.10
1.0
1.0
—
—
—
0
0
12
135
0.88
0.10
9.8
7.2
88.53
94.28
%
0.43
12
135
10
114
0.87
0.09
2.5
2.1
1.23
1.11
%
—
10
114
6
57
1.05
0.08
1.3
1.5
—
—
—
0
0
5
61
0.82
0.08
1.4
1.4
—
—
—
0
0
5
62
0.80
0.08
1.0
1.2
3.96
3.73
mmol/l
—
5
56
29
275
1.06
0.07
1.8
1.8
—
—
—
0
0
252
2535
0.95
0.06
5.4
5.2
2.90
2.82
mmol/l
0.63
226
2317
11
100
1.10
0.05
4.5
4.0
2.11
1.59
%
0.87
11
95
10
110
0.91
0.05
2.5
2.0
0.66
0.64
%
—
10
110
60
609
0.98
0.02
2.0
1.5
20.52
22.34
nmol/l
0.46
50
504
46
453
1.02
0.01
3.2
3.7
14.07
156.38
ng/l
2.07
29
341
10
102
0.98
0.00
3.5
3.1
49.74
47.97
%
—
10
102
10
102
0.98
0.00
1.4
1.3
25.50
27.94
iu/l
—
10
87
28
278
1.01
0.00
1.8
1.8
—
—
—
0
0
10
99
1.01
0.00
1.5
1.7
—
—
—
0
0
11
111
0.99
0.00
2.2
2.9
25.47
25.48
mmol/l
0.00
11
111
75
745
1.01
0.00
1.7
1.6
1.31
1.33
mmol/l
0.07
60
623
5
53
0.94
0.00
1.4
1.3
0.55
0.88
nmol/l
—
5
38
7
69
1.01
0.00
3.3
2.2
78.43
96.77
%
—
7
64
0
9
0.00
-0.00
0.0
1.1
—
9.86
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
1.19
—
0
5
5
52
0.96
-0.00
5.4
4.2
59.40
59.13
%
—
5
52
0
7
0.00
-0.00
0.0
1.3
—
6.21
—
0
7
5
51
0.98
-0.00
1.4
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
5
58
0.86
-0.00
1.2
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_CORPUS_UTERI and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CORPUS_UTERI | 1.1 [0.88, 1.37] | 0.399 |
| Birth year | 0.993 [0.98, 1.0] | 0.102 |
During the follow-up period (1.1.1998 — 31.12.2019), 99 out of 929 females with CD2_BENIGN_CORPUS_UTERI died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_CORPUS_UTERI.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.113% | No data |
| 5 | 0.59% | No data |
| 10 | 1.357% | No data |
| 15 | 2.656% | No data |
| 20 | 4.619% | No data |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CORPUS_UTERI – Other benign neoplasm of uterus: Corpus uteri
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data